Oxazinanes
Aobchem 2-Chloro-6-(methylsulfanyl)benzaldehyde | ≥97% | CAS 201987-39-5 | C8H7ClOS | 500mg
2-Chloro-6-(methylsulfanyl)benzaldehyde | ≥97% | CAS 201987-39-5 | C8H7ClOS | 500mg
Aobchem 6-Bromo-7-fluoro-2-methyl-2H-indazole | ≥95% | CAS 2665662-87-1 | C8H6BrFN2 | 250mg
6-Bromo-7-fluoro-2-methyl-2H-indazole | ≥95% | CAS 2665662-87-1 | C8H6BrFN2 | 250mg
Aobchem 6-Bromo-7-fluoro-2-methyl-2H-indazole | ≥95% | CAS 2665662-87-1 | C8H6BrFN2 | 5g
6-Bromo-7-fluoro-2-methyl-2H-indazole | ≥95% | CAS 2665662-87-1 | C8H6BrFN2 | 5g
Aobchem 5-Bromo-2 3-dihydro-1H-indene-1-carboxylic acid | ≥95% | CAS 1132943-94-2 | C10H9BrO2 | 5g
5-Bromo-2 3-dihydro-1H-indene-1-carboxylic acid | ≥95% | CAS 1132943-94-2 | C10H9BrO2 | 5g
Aobchem 3 4-DIHYDRO-2H-1 5-BENZODIOXEPIN-7-YLBORONIC ACID | ≥95% | CAS 279261-89-1 | C9H11BO4 | 500mg
3 4-DIHYDRO-2H-1 5-BENZODIOXEPIN-7-YLBORONIC ACID | ≥95% | CAS 279261-89-1 | C9H11BO4 | 500mg
Aobchem 4-Bromo-3 6-dihydro-2H-thiopyran 1 1-dioxide | ≥97% | CAS 1195706-31-0 | C5H7BrO2S | 250mg
4-Bromo-3 6-dihydro-2H-thiopyran 1 1-dioxide | ≥97% | CAS 1195706-31-0 | C5H7BrO2S | 250mg
Aobchem 4 5-Dibromo-2-ethyl-2H-1 2 3-triazole | ≥97% | CAS 1248676-21-2 | C4H5Br2N3 | 500mg
4 5-Dibromo-2-ethyl-2H-1 2 3-triazole | ≥97% | CAS 1248676-21-2 | C4H5Br2N3 | 500mg
Aobchem 3-Methyl-4-(methylsulfanyl)benzoic acid | ≥95% | CAS 851669-34-6 | C9H10O2S | 250mg
3-Methyl-4-(methylsulfanyl)benzoic acid | ≥95% | CAS 851669-34-6 | C9H10O2S | 250mg
Medchemexpress LLC Bomedemstat dihydrochloride | 99.6% | 592.54 | 10 MG
Bomedemstat (IMG-7289) dihydrochloride is an orally active and irreversible lysine-specific demethylase 1 (LSD1) inhibitor. It increases H3K4 and H3K9 methylation, which then alters gene expression. This compound exhibits anti-cancer activities by inhibiting cancer cell proliferation and inducing apoptosis.
- Orally active and irreversible lysine-specific demethylase 1 (LSD1) inhibitor.
- Increases H3K4 and H3K9 methylation.
- Alters gene expression.
- Shows anti-cancer activities.
- Inhibits cancer cell proliferation.
- Induces apoptosis.
Medchemexpress LLC Quisinostat (dihydrochloride) | 875320-31-3 | C21H28Cl2N6O2 | 5 MG
Quisinostat dihydrochloride is an orally active, potent pan-HDAC inhibitor with IC50s as low as 0.11 nM for HDAC1. This compound exhibits broad-spectrum antitumoral activity and can induce autophagy in neuroblastoma cells. It is intended for research use only.
- Orally active, potent pan-HDAC inhibitor
- Exhibits broad-spectrum antitumoral activity
- Induces autophagy in neuroblastoma cells
- Inhibits HDAC isozymes in vitro
- Shows broad-spectrum antiproliferative activity against cancer cell lines
- Induces apoptosis
- Induces H3 and H4 acetylation in A2780 ovarian carcinoma cells
- Inhibits growth of pre-established HCT116 colon xenografts in vivo
Medchemexpress LLC Bomedemstat dihydrochloride | 99.6% | 592.54 | 50 MG
Bomedemstat dihydrochloride is an orally active and irreversible lysine-specific demethylase 1 (LSD1) inhibitor. It increases H3K4 and H3K9 methylation to alter gene expression, showing anti-cancer activities by inhibiting cancer cell proliferation and inducing apoptosis.
- Orally active.
- Irreversible LSD1 inhibitor.
- Increases H3K4 and H3K9 methylation.
- Alters gene expression.
- Exhibits anti-cancer activities.
- Inhibits cancer cell proliferation.
- Induces apoptosis.
- Selectively inhibits proliferation and induces apoptosis of Jak2V617F cells.
- Enhances cell survival and induces apoptosis via BCL-XL and PUMA.
- Leads to cell cycle arrest.
- Normalizes or improves blood cell counts in animal models.
- Reduces spleen volumes in animal models.
- Restores normal splenic architecture.
- Reduces bone marrow fibrosis in animal models.
eMolecules 1149-23-1 | Diethyl 1,4-Dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate | Apollo Scientific US - Building Blocks | MFCD00005951 | 253.298 | C13H19NO4 | 95.000 | CCOC(=O)C1=C(C)NC(C)=C(C1)C(=O)OCC | 100g | 398005521
Diethyl 1,4-Dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate | Apollo Scientific US - Building Blocks | 1149-23-1 | MFCD00005951 | 253.298 | C13H19NO4 | 95.000 | CCOC(=O)C1=C(C)NC(C)=C(C1)C(=O)OCC | 100g | 398005521
eMolecules 1818847-43-6 | 1-methylazetidin-3-one hydrochloride | Advanced ChemBlocks - In Stock | MFCD29060167 | 121.560 | C4H8ClNO | 97.000 | Cl.CN1CC(=O)C1 | 250mg | 381422434
1-methylazetidin-3-one hydrochloride | Advanced ChemBlocks - In Stock | 1818847-43-6 | MFCD29060167 | 121.560 | C4H8ClNO | 97.000 | Cl.CN1CC(=O)C1 | 250mg | 381422434
Selleck Chemical LLC Triflupromazine hydrochloride
Triflupromazine hydrochloride (Fluopromazine) is an antipsychotic medication of the phenothiazine class